Search results « trips plus »
-
24-Apr-2019 CETRI
Numérisation de l’agriculture : quels risques pour les paysans et populations du Sud ?
Les marchés traditionnels font face à une concurrence croissante de la part des nouvelles formes de commerce de détail, qu’on appelle parfois « e-commerce » ou « e-épicerie ».
-
14-Mar-2019 L’Usine Santé
Les compagnies pharmaceutiques de plus en plus impliquées en matière d’arbitrage d’investissement
Ces dernières années marquent l’intérêt grandissant des sociétés pharmaceutiques internationales pour l’arbitrage à l’encontre d’États.
-
24-Aug-2016 Radio New Zealand
Trade ministers petitioned to hold off on PACER-Plus
Signed by 55 Pacific civil society organisations and over 200 individuals, the petition calls for no conclusion to be made on PACER-Plus until all the texts have been released and there has been an independent social impact assessment of the proposed deal.
-
24-Aug-2016 Radio New Zealand
Trade ministers petitioned to hold off on PACER-Plus
Signed by 55 Pacific civil society organisations and over 200 individuals, the petition calls for no conclusion to be made on PACER-Plus until all the texts have been released and there has been an independent social impact assessment of the proposed deal.
-
25-Apr-2013 Infojustice
Investors’ IP rights unbound: The danger of investment clauses to access to medicines
Although access to medicines activists have been wise to focus our attention intently on convincing low- and middle-income countries to adopt and use all possible TRIPS-compliant flexibilities and to oppose the TRIPS-plus IP chapters in free trade agreements, we have neglected to interrogate another chapter in free trade agreements and bilateral investment treaties that perhaps pose an even greater threat to our collective access to medicines – investment chapters.
-
25-Apr-2013 Infojustice
Investors’ IP rights unbound: The danger of investment clauses to access to medicines
Although access to medicines activists have been wise to focus our attention intently on convincing low- and middle-income countries to adopt and use all possible TRIPS-compliant flexibilities and to oppose the TRIPS-plus IP chapters in free trade agreements, we have neglected to interrogate another chapter in free trade agreements and bilateral investment treaties that perhaps pose an even greater threat to our collective access to medicines – investment chapters.
-
28-Feb-2006 ICTSD/UNCTAD
Intellectual property provisions of bilateral and regional trade agreements in light of US federal law
The critical lesson for developing countries accepting IPRs commitments in FTAs with the United States is that US IPRs law is replete with exceptions to the general rules, in many cases elaborated in considerable detail. If developing countries accept obligations in the FTAs, they must also be prepared to implement a significant level of exceptions so as to create a reasonable balance within their own law. If they do not implement these exceptions, they will find themselves not only with TRIPS-plus levels of IPRs protection, but also with US-plus levels of IPRs protection.
-
28-Feb-2006 ICTSD/UNCTAD
Intellectual property provisions of bilateral and regional trade agreements in light of US federal law
The critical lesson for developing countries accepting IPRs commitments in FTAs with the United States is that US IPRs law is replete with exceptions to the general rules, in many cases elaborated in considerable detail. If developing countries accept obligations in the FTAs, they must also be prepared to implement a significant level of exceptions so as to create a reasonable balance within their own law. If they do not implement these exceptions, they will find themselves not only with TRIPS-plus levels of IPRs protection, but also with US-plus levels of IPRs protection.
-
20-Sep-2021 Socialist Project
Multinational corporations and COVID-19: Intellectual property rights vs. human rights
Transnational companies today rely more than ever on IPR to structure their global value chains, writes Peter Rossman
-
20-Sep-2021 Socialist Project
Multinational corporations and COVID-19: Intellectual property rights vs. human rights
Transnational companies today rely more than ever on IPR to structure their global value chains, writes Peter Rossman